Showing results (1111-1120 of 1,131) with videos related to
Sort By:
Pageof 114
Nature Genetics|January 8, 2020
The Indian cobra reference genome and transcriptome enables comprehensive identification of venom toxinsKushal Suryamohan, Sajesh P Krishnankutty, Joseph Guillory, et al.South Asian Journal of Cancer|December 22, 2025
Consensus Statements for Clinical Practice in Advanced/Metastatic Colorectal Cancers in India Using a Modified Delphi MethodAnant Ramaswamy, Sujay Srinivas, Viraj Lavingia, et al.Human Vaccines & Immunotherapeutics|December 12, 2024
Immunogenicity and safety following a homologous booster dose of a SARS-CoV-2 recombinant spike protein vaccine with Matrix-MTM adjuvant (NVX-CoV2373) versus a primary series in people living with and without HIV-1 infection in South Africa: A randomized crossover phase 2a/2b trialVivek Shinde, Anthonet Lombard Koen, Zaheer Hoosain, et al.Journal of Healthcare Engineering|March 25, 2016
Healthcare Engineering Defined: A White PaperMing-Chien Chyu, Tony Austin, Fethi Calisir, et al.Acta Anaesthesiologica Scandinavica|February 14, 2021
Higher vs lower doses of dexamethasone in patients with COVID-19 and severe hypoxia (COVID STEROID 2) trial: Protocol and statistical analysis planM W Munch, Anders Granholm, S N Myatra, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 28, 2022
Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant TherapyJulio Garcia-Aguilar, Sujata Patil, Marc J Gollub, et al.The Lancet. HIV|April 30, 2022
Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trialShabir A Madhi, Dhayendre Moodley, Sherika Hanley, et al.The New England Journal of Medicine|May 5, 2021
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 VariantVivek Shinde, Sutika Bhikha, Zaheer Hoosain, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2023
Long-Term Results of Organ Preservation in Patients With Rectal Adenocarcinoma Treated With Total Neoadjuvant Therapy: The Randomized Phase II OPRA TrialFloris S Verheij, Dana M Omer, Hannah Williams, et al.Intensive Care Medicine|November 10, 2021
Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxaemia: a pre-planned, secondary Bayesian analysis of the COVID STEROID 2 trialAnders Granholm, Marie Warrer Munch, Sheila Nainan Myatra, et al.Pageof 114